Opendata, web and dolomites

SUDOCHIP

New antiperspirant efficacy evaluation techniques based on a disruptive microfluidic technology

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 SUDOCHIP project word cloud

Explore the words cloud of the SUDOCHIP project. It provides you a very rough idea of what is the project "SUDOCHIP" about.

formulations    administration    components    ap    first    consuming    last    countries    suppliers    armpit    requesting    free    faster    predefined    volunteers    prototype    smes    carcinogenic    phase1    dominate    jobs    2015    2023    reduce    adults    cheaper    fear    sweat    validation    million    direct    validated    36    unreliable    business    protocol    skin    otherwise    room    microfactory    instrument    accelerate    changed    antiperspirants    prioritise    efforts    considerable    almost    subjects    mimics    industry    food    microfluidic    measured    axillae    finalise    aluminium    invented    drive    standard    perfectly    twenty    explore    performed    time    10k    gravimetry    human    cosmetic    regulates    sales    precisely    expensive    few    world    20bn    successfully    exempt    40    natural    commercial    technique    drug    87    efficacy    artificial    paradigm    hundred    hot    unadapted    create    groups    turnover    global    road    ingredients    international    vivo    market    marketing    raw    reproducible    sweating    gold    techniques    aps    leaders    minutes    generate    cancer   

Project "SUDOCHIP" data sheet

The following table provides information about the project.

Coordinator
MICROFACTORY 

Organization address
address: 10 RUE VAUQUELIN
city: PARIS
postcode: n.a.
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country France [FR]
 Project website http://www.microfactory.eu
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.2.1.5. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Advanced manufacturing and processing)
2. H2020-EU.2.1.3. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Advanced materials)
3. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument)
4. H2020-EU.2.1.2. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies – Nanotechnologies)
 Code Call H2020-SMEINST-1-2016-2017
 Funding Scheme SME-1
 Starting year 2017
 Duration (year-month-day) from 2017-08-01   to  2018-01-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    MICROFACTORY FR (PARIS) coordinator 50˙000.00

Map

 Project objective

Antiperspirants (APs) are among the most widely used cosmetic products that reduce sweat in the axillae (€20bn market in 2015). They are used by almost 90 % of the adults in developed countries. The Food and Drug Administration regulates APs, and gravimetry is the gold standard technique used to test them. More precisely, a direct application of the test sample on the armpit is performed on 40 volunteers and sweating is measured under predefined conditions in a hot room. This technique, which has not changed for the last twenty years, is time-consuming (a month), expensive (up to 10K€), and unreliable (/- 40%). Due to consumer fear that aluminium in APs may cause cancer, aluminium-free, “natural” APs will dominate the market. A change of paradigm is down the road, requesting the design and test of a considerable number of new formulations, for which the existing methods are clearly unadapted. Microfactory has invented a new microfluidic instrument and AP efficacy testing protocol using natural or artificial sweat that perfectly mimics the in vivo skin sweating process. The test does not require human subjects, is one hundred time faster (few minutes), is cheaper than other techniques, and is highly reproducible. The first prototype has been successfully validated by two world leaders in the cosmetic industry. It will accelerate the design of new antiperspirants with more natural ingredients exempt of carcinogenic components, that would otherwise take many years to develop using the current techniques. The Phase1 objective is to finalise instrument validation over a new range of aluminium free commercial APs and to explore and prioritise new market applications. For Microfactory, it will open new global business opportunities with major international cosmetic groups, SMEs and suppliers of raw cosmetic ingredients. It will generate an ambitious turnover of €36 million in 2023, as well as create 87 new European jobs to drive development, marketing and sales efforts.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "SUDOCHIP" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "SUDOCHIP" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.2.1.5.;H2020-EU.2.1.3.;H2020-EU.2.3.1.;H2020-EU.2.1.2.)

SUPPLEPRINT (2018)

Super Productive Line Printing Inkjet

Read More  

Volumizer (2018)

A natural, non-surgical, and safe facial filler which treats the root cause of facial ageing.

Read More  

STAR (2018)

Safe, Transparent, Active and Reliable mineral sunscreen technology

Read More